|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Tranacriptional Regulators of the Human Multidrug Resistance 1 Gene:Recent Views 显示文摘 | Labialle S Gayet L Marthinet E | 2002 | Biochem Pharmacol2002，64，56： | 1 |
| 2 | Combined search for anti-β2 glycoprotein Ⅰ and anticardiolipin antibodies in antiphospholipid syndrome:contribution to diagnosis显示文摘 | Sanmarco M Roll P Gayet S | 2004 | J Lab Clin Med2004，144，3： | 1 |
| 3 | Transcriptional regulators of the human multidrug resistance 1 gene:recent views显示文摘 | Labialle S Gayet L Marthinet E | 2002 | Biochem Pharmacol2002，64，： | 1 |
| 4 | Transcriptional regulators of the human multidrug resistance 1 gene recent views 显示文摘 | Labialle S Gayet L Marthinet E | 2002 | Biochem phamacol2002，64，2： | 1 |
| 5 | Shrinking lung syndrome and systemic auto-immune disease显示文摘 | Branger S Schleinitz N Gayet S | 2004 | Rev Med Interne2004，25，1： | 1 |
| 6 | Transcriptional regulators of the human multidrug resistance 1 gene: recent views 显示文摘 | Labialle S Gayet L Marthinet E | 2002 | Biochem Pharmacol2002，64，5： | 1 |
| 7 | Transcriptional regulators of the human muhidrug resistance 1 gene: recent views 显示文摘 | Labialle S Gayet L Marthinet E | 2002 | Bio- chem Pharmacol2002，64，56： | 1 |
| 8 | Tranac riptional regulatots of the human muhidrug resistance 1 gene: recent views显示文摘 | Labialle S Gayet L Marthinet E | 2002 | Biochem Pharmacol2002，64，56： | 1 |
| 9 | Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains 显示文摘 | Gayet S Chollet R Molle G | 2003 | Antimicrob Agents Chemother2003，47，5： | 1 |
| 10 | Transcriptional regulators of the human multidrug resistance 1 gene:recentviews显示文摘 | Labialle S Gayet L Marthinet E | 2002 | Biochem Pharmacol2002，64，526： | 1 |
| 11 | A com- mon highly conserved cadmium detoxification mecha- nism from bacteria to humans: heavy metal tolerance conferred by the ATP-binding cassette (ABC) trans- porter SpHMT1 requires GSH but not metal-chelating phytochelatin peptides 显示文摘 | PREVERAL S GAYET L MOLDES C | 2009 | Journal of Biological Chem- istry2009，284，8： | 1 |
| 12 | Transcriptional regulators of the human multdrugresistance1 gene:recent views显示文摘 | Labialle S Gayet L Marthinet E | 2002 | Biochem Pharmacol2002，64，56： | 1 |
| 13 | Transcriptional regulators of the human mult-idrug resistance 1 gene: recent views显示文摘 | Labialle S Gayet L Marthinet E | 2002 | Biochem Pharmacol2002，64，： | 1 |
| 14 | Transcriptional regulators of the human multdrugresistance1 gene:recent views显示文摘 | Labialle S Gayet L Marthinet E | 2002 | Bio Chem Pharmacol2002，64，56： | 1 |
| 15 | Transcriptional regulators of the human multidrug resistance 1 gene:recent views显示文摘 | Labialle S Gayet L Marthinet E | 2002 | Biochem Pharmacol2002，6，： | 1 |
| 16 | Transcriptional regulators of the human multidrug resistance 1 gene:recent views显示文摘 | Labialle S Gayet L Marthinet E | 2002 | Biochem Pharmacol2002，64，56： | 1 |
| 17 | Transcriptional regulators of the human multdrug resistance 1 gene:recent views显示文摘 | Labialle S Gayet L Marthinet E | 2002 | Biochem Pharmacol2002，64，6： | 1 |
| 18 | Consequences of metabolic syndrome on postoperative outcomes after pancreaticoduodenectomy显示文摘AIM To analyze immediate postoperative outcomes after pancreaticoduodenectomy regarding metabolic syndrome.METHODS In two academic centers, postoperative outcomes of patients undergoing pancreaticoduodenectomy from 2002 to 2014 were prospectively recorded. Patients presenting with metabolic syndrome [defined as at least three criteria among overweight(BMI ≥ 28 kg/m2), diabetes mellitus, arterial hypertension and dyslipidemia] were compared to patients without metabolic syndrome.RESULTS Among 270 consecutive patients, 29(11%) presented with metabolic syndrome. In univariable analysis, patients with metabolic syndrome were significantly older(69.4 years vs 62.5 years, P = 0.003) and presented more frequently with soft pancreas(72% vs 22%, P = 0.0001). In-hospital morbidity(83% vs 71%) and mortality(7% vs 6%) did not differ in the two groups so as pancreatic fistula rate(45% vs 30%, P = 0.079) and severity of pancreatic fistula(P = 0.257). In multivariable analysis, soft pancreas texture(P = 0.001), pancreatic duct diameter < 3 mm(P = 0.025) and BMI > 30 kg/m2(P = 0.041) were identified as independent risk factors of pancreatic fistula after pancreaticoduodenectomy, but not metabolic syndrome.CONCLUSION In spite of logical reasoning and appropriate methodology, present series suggests that metabolic syndrome does not jeopardize postoperative outcomes after pancreaticoduodenectomy. Therefore, definition of metabolic syndrome seems to be inappropriate and fatty pancreas needs to be assessed with an international consensual histopathological classification. | Alban Zarzavadjian Le Bian David Fuks Sophie Chopinet Sébastien Gaujoux Manuela Cesaretti Renato Costi Ajay P Belgaumkar Claude Smadja Brice Gayet | 2017 | World Journal of Gastroenterology2017，23，17： | 1 |
| 19 | Near infi'ared fluorescence imaging of rabbit thyroid and parathyroid glands显示文摘 | Antakia R Gayet P Guillermet S | 2014 | J Surg Res2014，192，2： | 1 |
| 20 | Control of P- glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells 显示文摘 | Gayet L Dayan G Barakat S | 2005 | Biochemistry2005，44，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员